[Federal Register Volume 87, Number 19 (Friday, January 28, 2022)]
[Notices]
[Pages 4628-4629]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-01764]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


National Biodefense Science Board

AGENCY: Office of the Assistant Secretary for Preparedness and Response 
(ASPR), Department of Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The National Biodefense Science Board (NBSB or the Board) is 
authorized under Section 319M of the Public Health Service (PHS) Act, 
as added by Section 402 of the Pandemic and All-Hazards Preparedness 
Act of 2006 and amended by Section 404 of the Pandemic and All-Hazards 
Preparedness Reauthorization Act. The Board is governed by the Federal 
Advisory Committee Act, which sets forth standards for the formation 
and use of advisory committees. The NBSB provides expert advice and 
guidance on scientific, technical, and other matters of special 
interest to the Department of Health and Human Services (HHS) regarding 
current and future chemical, biological, nuclear, and radiological 
agents, whether naturally occurring, accidental, or deliberate. 
Authority to manage and operate the NBSB, including to receive advice 
and recommendations from the Board, has been delegated by the Secretary 
of HHS to the Assistant Secretary for Preparedness and Response (ASPR). 
The NBSB will meet in public (virtually) on March 7, 2022, beginning at 
12:30 p.m. Eastern time. ASPR invites stakeholders and the general 
public to attend and participate as appropriate. A detailed agenda and 
instructions to register to attend the meeting will be available on the 
NBSB meeting website https://www.phe.gov/nbsb.
    Procedures for Public Participation: Members of the public may 
attend the meeting via a toll-free phone number or Zoom teleconference, 
which requires pre-registration. The meeting link to pre-register will 
be posted on the meeting website https://www.phe.gov/

[[Page 4629]]

nbsb. Members of the public may provide written comments or submit 
questions for consideration by the NBSB at any time via email to 
<a href="/cdn-cgi/l/email-protection#521c100110123a3a217c353d24"><span class="__cf_email__" data-cfemail="baf4f8e9f8fad2d2c994ddd5cc">[email protected]</span></a>.
    Additionally, the NBSB invites stakeholders to request up to seven 
minutes to address the Board in-person during the meeting. The Board is 
interested in hearing from anyone involved in, or who represents, a 
relevant biomedical, biodefense, or health security industry; serves as 
faculty or conducts research at an academic institution; occupies a 
relevant health profession or works for a hospital system or health 
care consumer organization; or who serves in a relevant state, Tribal, 
territorial, or local government agency. Requests to provide remarks to 
the NBSB during the public meeting must be sent to <a href="/cdn-cgi/l/email-protection#f7b9b5a4b5b79f9f84d9909881"><span class="__cf_email__" data-cfemail="632d213021230b0b104d040c15">[email protected]</span></a> by 
March 1, 2022. In that request, please provide the speaker's name, 
title, and position, with a brief description of the topic that they 
will address. The number of speakers and topics will be based on 
relevance to the mission of the NBSB and amount of time available on 
the agenda. The charter of the NBSB may be reviewed on the ASPR/NBSB 
website. Topics and presentations with an obvious commercial bias, to 
include any form of advertising, marketing, or solicitation, will not 
be accepted.

FOR FURTHER INFORMATION CONTACT: CAPT Christopher L. Perdue, MD, MPH, 
NBSB Designated Federal Official, Washington, DC, <a href="/cdn-cgi/l/email-protection#014f435243416969722f666e77"><span class="__cf_email__" data-cfemail="014f435243416969722f666e77">[email protected]</span></a>.

Dawn O'Connell,
Assistant Secretary for Preparedness and Response.
[FR Doc. 2022-01764 Filed 1-27-22; 8:45 am]
BILLING CODE 4150-37-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>